Replies to post #1153 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>GTCB should do more to support interest in the stock, i definitely hope 2007 will make them attend more investor presentations…<

You won’t have to wait until 2007—GTC is giving four investor presentations in the next two months: #msg-13764967, #msg-13864262.

…>…specifically pitching a 3-5 year path starting with a boost from the fda next summer…<

FDA approval of ATryn is slated for 2008, not 2007. But I agree about the need to present a coherent 3-5 year plan and that’s what I expect to be hearing at some of the conferences.